.Merck defeats incomes expectations, rears sales outlook on sturdy requirement for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Forecasts as Keytruda Sales Growth BloombergMerck Inventory: Pharma Titan Posts Strong End Results, Yet Outlook Drops Short Capitalist's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income as well as sales desires amidst Keytruda asset, yet delivers mixed full-year expectation MarketWatch.